John A Vest MD
Cardiac Electrophysiology
Assistant Professor, Medicine, Columbia University College of Phys &
Join to View Full Profile
New York Presbyterian Hospital630 West 168th Street, Ph3-347New York, NY 10032
Phone+1 212-305-8194
Are you Dr. Vest?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Vest, MD is a cardiologist in New York, New York. He is an Assistant Professor at Columbia University College of Phys &.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Clinical Cardiac Electrophysiology, 2006 - 2007
New York Presbyterian Hospital(Cornell Campus)/Coney Island HospitalFellowship, Cardiovascular Disease, 2002 - 2006- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 2002
Columbia University Vagelos College of Physicians and SurgeonsClass of 1998
Publications & Presentations
PubMed
- Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis: Proceedings of the Amyloidosis Forum.Sharmila Dorbala, Rosalyn Adigun, Kevin M Alexander, Michela Brambatti, Sarah A M Cuddy
JACC. Cardiovascular Imaging. 2025-02-20 - 33 citationsVutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.Marianna Fontana, John L Berk, Julian D Gillmore, Ronald M Witteles, Martha Grogan
The New England Journal of Medicine. 2025-01-02 - 23 citationsImpact of vutrisiran on exploratory cardiac parameters in hereditary transthyretin-mediated amyloidosis with polyneuropathy.Pablo Garcia-Pavia, Martha Grogan, Parag Kale, John L Berk, Mathew S Maurer
European Journal of Heart Failure. 2024-02-01
Press Mentions
Alnylam Announces New Data from ATTR Amyloidosis Programs at the Peripheral Nerve Society’s 2021 Annual MeetingJune 7th, 2021- FDA Panel Supports Patisiran for ATTR Amyloidosis with CardiomyopathySeptember 15th, 2023
